Clinical trial Recruiting at 1 site Observational Ages 18 and up

Non-invasive intracranial pressure monitoring with a skull-mounted sensor

Official title: Non-Invasive Intracranial Pressure Waveform Dynamics

Run by University of Texas Southwestern Medical Center · NCT07113353 · Data updated 2026-11-12

Researchers will try a small skull-mounted sensor to see if it records intracranial pressure waveforms like invasive monitors in adults who are having craniotomy, lumbar puncture, or shunt adjustment procedures.

More Intracranial Pressure trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment30 (estimated)
SponsorUniversity of Texas Southwestern Medical Center
Academic / other
Locations1 site (Coppell, Texas)
StatusRecruiting
StartedApril 10, 2026
Main results expectedOctober 1, 2026
Study endsOctober 1, 2027
Registry record updatedApril 22, 2026
Trial IDNCT07113353 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults over 18 who can provide informed consent and who are undergoing craniotomy with planned hyperosmolar therapy, diagnostic/therapeutic lumbar puncture, or ventriculo-peritoneal shunt adjustment are the intended participants.

Probably not a fit

Children under 18, patients lacking the capacity to consent, and adults not undergoing the specified procedures are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study uses a Brain4Care non-invasive monitor with piezoelectric sensors placed on the scalp to capture tiny skull pulsations that produce ICP-like waveforms. Waveform metrics such as the P2/P1 ratio and time to peak (TTP) will be compared to clinical changes during procedures that alter intracranial pressure (craniotomy with hyperosmolar therapy, diagnostic/therapeutic lumbar puncture, and ventriculo-peritoneal shunt adjustments). Although the device has prior validation and an FDA clearance for waveform equivalence, the study will characterize how those waveforms change in response to ICP-lowering maneuvers. All measurements are collected during routine clinical care at UT Southwestern in consenting adults.

Why it matters

Potential benefit: If successful, the device could allow non-invasive, bedside monitoring of intracranial pressure waveforms, reducing the need for invasive probes and enabling earlier intervention.

How similar studies have gone: Prior validation work and an FDA clearance support waveform equivalence between this non-invasive device and invasive ICP monitors, but its response during ICP-lowering maneuvers is not yet fully characterized.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult patients (age \>18) undergoing craniotomy for any indication requiring hyperosmolar agents as a part of their surgery
* Adult patients (age \>18) in the neuro-oncology or neurosurgery clinic who are receiving diagnostic/therapeutic lumbar puncture as a part of their ordinary care
* Adult patients (age \>18) in the neurosurgery clinic with ventriculo-peritoneal shunts who require adjustments to increase or decrease drainage of cerebrospinal fluid.

Exclusion Criteria:

* Age \<18
* Lacking capacity to provide informed consent on their own behalf

Where it's running

  • UT Southwestern Medical Center
    Coppell, Texas, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.